|
Dr. Zhang had 12 years Pharmaceutical industry experience from Eli Lilly and Company. He had served as Global Head of Drug Discovery and Development Statistics and Information Sciences with responsibility in managing 7 information science groups in the field of Systems Biology, Genomics, Assay development, Chemoinformatics, and Tox/ADME statistics. Prior to the management role, he was a senior research scientist at Lilly leading the protein kinase/phosphatase crystal structure platform. He is one of the major contributors of the clinical candidate for cell cycle kinase inhibitors. Dr. Zhang was also pointed as project coordinator of anti-infectious disease target selection team responsible for 14 S. pneumoniae drug target selection from gene database to expression and crystallization. Dr. Zhang was the co-inventor of sever patents in the area of kinase inhibitors and novel anti-obesity protein therapeutics. Dr. Zhang received his Ph.D in Biochemistry and Molecular Biology from Institute of Biophysics, Chinese Academy of Sciences and MBA degree from Kelly business school, Indiana University. He had a 4 year postdoctoral training in Protein Crystallography from University of Texas Southwestern Medical Center in Dallas and Photon Factory in Japan prior to joining Eli Lilly and Company. He is also an associate professor of Chemistry and Biochemistry program at Indiana University. Dr. Zhang has authored more than 30 scientific publications including 2 Nature articles. Prior to joining Crown, Dr. Zhang has spent 12 years at Eli Lilly & Co. While at Lilly, he served as Global Head of Drug Discovery and Development, Statistics and Information Sciences. Prior to that, Dr. Zhang led Lilly's protein kinase/phosphatase crystal structure platform. He is the co-inventor of several patents in the area of kinase inhibitors and novel anti-obesity protein therapeutics. He also played a major role in the progression of cell cycle kinase inhibitors to the clinic. Dr. Zhang received his Ph.D in Biochemistry and Molecular Biology from Inst. of Biophysics, Chinese Academy of Sciences and an MBA from Kelly Business School, Indiana University. He had 4 year of postdoctoral training in Protein Crystallography from U. of Texas Southwestern Medical Center in Dallas. He is also an Assoc. Professor of Chemistry and Biochemistry at Indiana University. Dr. Zhang has authored more than 30 scientific publications. | 